# Omega Fundamentals

OMGA | Stock | ## USD 5.42 0.29 5.65% |

Omega Therapeutics fundamentals help investors to digest information that contributes to Omega Therapeutics' financial success or failures. It also enables traders to predict the movement of Omega Stock. The fundamental analysis module provides a way to measure Omega Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omega Therapeutics stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Omega |

## Omega Short Ratio Analysis

Omega Therapeutics' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.## Current Omega Therapeutics Short Ratio | 2.07 X |

Most of Omega Therapeutics' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omega Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

Compare to competition |

Based on the latest financial disclosure, Omega Therapeutics has a Short Ratio of 2.07 times. This is 46.92% lower than that of the Healthcare sector and 72.06% lower than that of the Biotechnology industry. The short ratio for all United States stocks is 48.25% higher than that of the company.

## Omega Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Omega Therapeutics's current stock value. Our valuation model uses many indicators to compare Omega Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omega Therapeutics competition to find correlations between indicators driving Omega Therapeutics's intrinsic value. More Info.## Omega Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omega Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omega Therapeutics could also be used in its relative valuation, which is a method of valuing Omega Therapeutics by comparing valuation metrics of similar companies.Omega Therapeutics is currently under evaluation in net income category among related companies.

## Omega Therapeutics Institutional Holders

Institutional Holdings refers to the ownership stake in Omega Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Omega Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Omega Therapeutics' value.Security Type | Shares | Value | ||

Flagship Pioneering Inc | Common Shares | 25.9 M | 98.4 M | |

Fmr Llc | Common Shares | 4.4 M | 16.7 M | |

Harbourvest Partners Llc | Common Shares | 2.6 M | 10.1 M | |

Artal Group Sa | Common Shares | 2.3 M | 8.6 M | |

State Of Wisconsin Investment Board | Common Shares | 1.9 M | 7.1 M | |

Chi Advisors Llc | Common Shares | 1.1 M | 4 M | |

Vanguard Group Inc | Common Shares | 749.6 K | 2.8 M |

## Omega Fundamentals

Return On Equity | (49.30) % | |||

Return On Asset | (25.27) % | |||

Current Valuation | 67.41 M | |||

Shares Outstanding | 47.77 M | |||

Shares Owned by Insiders | 3.73 % | |||

Shares Owned by Institutions | 91.20 % | |||

Number of Shares Shorted | 538.79 K | |||

Price to Book | 1.11 X | |||

Price to Sales | 594.87 X | |||

Revenue | 412 K | |||

Gross Profit | (47.72 M) | |||

EBITDA | (71.59 M) | |||

Net Income | (74.96 M) | |||

Cash and Equivalents | 200.8 M | |||

Cash per Share | 4.20 X | |||

Total Debt | 24.18 M | |||

Debt to Equity | 0.13 % | |||

Current Ratio | 15.23 X | |||

Book Value Per Share | 4.61 X | |||

Cash Flow from Operations | (70.41 M) | |||

Short Ratio | 2.07 X | |||

Earnings Per Share | (5.03) X | |||

Number of Employees | 79 | |||

Market Capitalization | 245.09 M | |||

Z Score | 6.0 |

## About Omega Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Omega Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omega Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omega Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Omega Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Omega Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Omega Therapeutics' short interest history, or implied volatility extrapolated from Omega Therapeutics options trading.

## Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Omega Therapeutics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.## Build Optimal Portfolios

### Align your risk with return expectations

Please check Omega Therapeutics Piotroski F Score and Omega Therapeutics Altman Z Score analysis. Note that the Omega Therapeutics information on this page should be used as a complementary analysis to other Omega Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

## Complementary Tools for Omega Stock analysis

When running Omega Therapeutics price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.

Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | Go | |

My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | Go | |

Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account | Go | |

Probability Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years | Go | |

Bond DirectoryFind actively traded corporate debentures issued by US companies | Go |

Is Omega Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Omega Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.